A phase I study of lenalidomide with pioglitazone, dexamethasone and low-dose treosulfan: Combined anti-inflammatory, immunomodulatory and angiostatic treatment as third-line therapy for patients (pts) suffering from multiple myeloma (MM)

Reichle, A. and Vogelhuber, M. and Kreuser, E. -D. and Wilke, J. and Wagner, H. and Straka, C. and Pronath, A. and Andreesen, R. (2011) A phase I study of lenalidomide with pioglitazone, dexamethasone and low-dose treosulfan: Combined anti-inflammatory, immunomodulatory and angiostatic treatment as third-line therapy for patients (pts) suffering from multiple myeloma (MM). ONKOLOGIE, 34 (Suppl6). p. 160. ISSN 0378-584X

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 05 May 2020 06:20
Last Modified: 05 May 2020 06:20
URI: https://pred.uni-regensburg.de/id/eprint/20261

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.